Pulse Biosciences, Inc (PLSE) vs Teleflex Incorporated (TFX)

Pulse Biosciences, Inc and Teleflex Incorporated are both Medical Instruments & Supplies companies. Teleflex Incorporated is the larger, with a market value of $6.5B against $3.9B — 1.7× the size. Pulse Biosciences, Inc grew revenue faster over the last twelve months: 90.1% against 30.7%. Teleflex Incorporated has the higher net margin (−45.8% vs −5,609.4%) and the higher return on invested capital (0.51% vs −37.0%). Across the 17 metrics below, Teleflex Incorporated leads on 11 and Pulse Biosciences, Inc on 6.

Valuation

Metric PLSE TFX Medical Instruments & Supplies median
P/E n/m n/m 30.28
P/S 2,558.93 2.94 2.49
P/B 20.83 2.28 2.34
Price to free cash flow n/m 124.77 23.49
EV/EBITDA n/m 35.66 14.87
EV/Sales 2,578.39 4.05 2.75
Earnings yield (2.28%) (15.30%) 0.00%
Free cash flow yield (5.65%) 0.80% 0.59%

Profitability

Metric PLSE TFX Medical Instruments & Supplies median
Gross margin 26.77% 54.94% 53.60%
Operating margin (5,821.08%) 1.97% 1.97%
Net margin (5,609.44%) (45.76%) 0.00%
Free cash flow margin (14,462.52%) 2.36% 2.36%
Return on equity (60.67%) (28.87%) 0.00%
Return on assets (54.01%) (14.57%) 0.00%
Return on invested capital (37.01%) 0.51% 0.13%

Growth

Metric PLSE TFX Medical Instruments & Supplies median
Revenue growth (TTM) 90.08% 30.70% 8.97%
EPS growth (last fiscal year) (17.39%) (1,468.24%) 6.51%
Revenue growth, 5-year CAGR — (4.72%) 8.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PLSE TFX Medical Instruments & Supplies median
Debt to equity 0.00 0.97 0.10
Current ratio 14.35 2.60 2.47
Net debt to EBITDA 1.06 7.52 0.97

Dividend

Metric PLSE TFX Medical Instruments & Supplies median
Dividend yield — 0.89% 1.02%
Payout ratio — — 0.27

Size

Metric PLSE TFX Medical Instruments & Supplies median
Market cap 3.86b 6.45b 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack